{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T16:32:26Z","timestamp":1778257946031,"version":"3.51.4"},"reference-count":39,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2009,4,20]],"date-time":"2009-04-20T00:00:00Z","timestamp":1240185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\/Aims: <\/jats:bold> BALB\/c mice with a homozygous deficiency in the <jats:italic>Tgfb1<\/jats:italic> gene are a model of fulminant autoimmune hepatitis (AIH), spontaneously and rapidly developing Th1\u2010mediated IFN\u2010\u03b3\u2010dependent necroinflammatory liver disease. We sought to understand the molecular basis for fulminant Th1 liver disease and the specific role of the <jats:italic>Ifng<\/jats:italic> gene.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> Global gene expression in livers from BALB\/c <jats:italic>Tgfb1<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice with and without an intact <jats:italic>Ifng<\/jats:italic> gene was assessed by microarray analysis. Expression patterns were confirmed by quantitative reverse transcriptase\u2010polymerase chain reaction. Gene ontology clustering analysis was performed to identify altered pathways. The contributions of <jats:italic>Ifng<\/jats:italic> to altered expression pathways were quantified.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Over 100 genes were strongly (&gt;10\u2010fold) upregulated, most encoding proteins involved in immune function\/response. Chemokines were the most prominently upregulated group, with eight chemokine genes upregulated &gt;10\u2010fold. <jats:italic>Ifng<\/jats:italic> was necessary for the upregulation of CXC chemokines gene, but not of CC chemokine genes. By quantitative analysis, <jats:italic>Ifng<\/jats:italic>'s role in liver gene upregulation varied greatly among overexpressed genes.<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> Gene expression changes indicate a particularly important and heretofore unappreciated role for chemokines in fulminant AIH. <jats:italic>Ifng<\/jats:italic> has an important role in expression of some but not all genes. <jats:italic>Ifng<\/jats:italic> is dichotomous in the regulation of distinct chemokine subfamilies: specifically, <jats:italic>Ifng<\/jats:italic> is critical for overexpression of specific CXCL genes but dispensable for overexpression of specific CCL genes. These results provide a clearer understanding of the role of <jats:italic>Ifng<\/jats:italic> in the molecular basis of necroinflammatory liver disease.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2009.02028.x","type":"journal-article","created":{"date-parts":[[2009,4,21]],"date-time":"2009-04-21T03:54:54Z","timestamp":1240286094000},"page":"1307-1315","source":"Crossref","is-referenced-by-count":12,"title":["The role of <i>Ifng<\/i> in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitis"],"prefix":"10.1111","volume":"29","author":[{"given":"Michael W.","family":"Milks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Cripps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Sargent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Whitfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Gorham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,9,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050408"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0016-5085(83)90030-6","article-title":"Autoimmune features as determinants of prognosis in steroid\u2010treated chronic active hepatitis of uncertain etiology","volume":"85","author":"Czaja AJ","year":"1983","journal-title":"Gastroenterology"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840040409"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-35705"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0528.2002.017401.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.03.008"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1568-9972(03)00017-X"},{"key":"e_1_2_6_9_2","first-page":"1075","article-title":"Liver tolerance mediated by antigen presenting cells","volume":"52","author":"Lau AH","year":"2003","journal-title":"fact or fiction?"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240619"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(94)80244-0"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.24.021605.090737"},{"key":"e_1_2_6_13_2","first-page":"6413","article-title":"Genetic regulation of autoimmune disease","volume":"166","author":"Gorham JD","year":"2001","journal-title":"BALB\/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.9.4785"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700246"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/4.2.249"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00051965"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1142\/9789812702456_0028"},{"key":"e_1_2_6_19_2","first-page":"R60.1","article-title":"DAVID","volume":"4","author":"Dennis G","year":"2003","journal-title":"database for annotation, visualization, and integrated discovery"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2004.08.004"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.3.1556"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1998.0426"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1678"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700439"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803417"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.1.129"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2000.17721.x"},{"key":"e_1_2_6_29_2","first-page":"4448","article-title":"Molecular aspects of rheumatoid arthritis","volume":"275","author":"Iwamoto T","year":"2008","journal-title":"chemokines in the joints of patients"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.2741\/2927"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2007.0267"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-12-061408"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-087403"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2008.00154.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.080350"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000244420.68037.86"},{"key":"e_1_2_6_37_2","first-page":"23","article-title":"Chemokine receptor antagonists","volume":"8","author":"Horuk R.","year":"2009","journal-title":"overcoming developmental hurdles"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2005.08.009"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01391.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1298"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2009.02028.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2009.02028.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T21:23:14Z","timestamp":1695936194000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2009.02028.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,3]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1478-3231.2009.02028.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2009.02028.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,3]]}}}